Expert Directory
Alexander B. Olawaiye, MD, FRCOG, FACOG, FACS
Professor and Vice Chair for Diversity and Inclusion
Department of Obstetrics, Gynecology, and Reproductive Sciences
Director, Minimal Access Gynecologic Oncology Surgery
Leader, Sponsored Clinical Trials & Partnership
University of Pittsburgh Medical Center
University of Pittsburgh School of Medicine
Pittsburgh, PA
Alexander B. Olawaiye, MD, FRCOG, FACOG, FACS, is a professor and vice chair for diversity and inclusion, Department of Obstetrics, Gynecology, and Reproductive Sciences, at the University of Pittsburgh School of Medicine in Pittsburgh, PA. He is also director of minimal access gynecologic oncology surgery and a leader in the Sponsored Clinical Trials & Partnership at his institution.
Dr Olawaiye is a medical graduate of the University of Ibadan, Nigeria. He underwent post-graduate training in obstetrics and gynecology and became a member (now a fellow) of the Royal College of Obstetricians and Gynaecologists, London, United Kingdom. He then trained in obstetrics and gynecology at The State University of New York at Buffalo. He completed his fellowship training in gynecologic oncology at Massachusetts General Hospital and Harvard Medical School, Boston, MA.
He specializes in gynecologic malignancies, including endometrial, ovarian, cervical, vulvar, and vaginal cancers. His research interests lie in translational and clinical research for endometrial, ovarian, cervical, and vulvar cancers, as well as chemotherapeutic agents and their complications. Dr Olawaiye is the GOG Foundation principal investigator for the University of Pittsburgh Cancer Institute and a co–principal investigator for the University of Pittsburgh Cancer Institute Ovarian Cancer SPORE program.
Dr Olawaiye is a member of the Executive Council and chair of the Female Reproductive Panel of the American Joint Committee on Cancer, a member of the Board of Directors and associate director of the GOG Foundation, and a member of the Board of Directors of the International Gynecologic Cancer Society.
Contributing Articles
The Initial Management of Advanced Ovarian Cancer
Treatment Options for Platinum-Resistant Ovarian Cancer
Delays and Disparities in the Diagnosis and Treatment of Endometrial Cancer
Conference Reporter® in Ovarian Cancer to Cover Key Topics Being Presented at ASCO 2025